Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists

US Patent 7423067 · Granted Sep 9, 2008

Estimated economic value: $191,116,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aza-benzothiophene compounds as STING agonists2023
Oxo-tetrahydro-isoquinoline carboxylic acids as STING inhibitors2022
Sting agonist compounds2020
Cyclic di-nucleotide compounds as sting agonists2020
Cyclic di-nucleotide compounds as STING agonists2020
Cyclic di-nucleotide compounds as STING agonists2020
Benzo[b]thiophene compounds as STING agonists2020
Benzo[b]thiophene compounds as STING agonists2020
Preparation of pharmaceutical dosage forms containing iron (III) salts2019
Benzo[b]thiophene compounds as sting agonists2019
Antidiabetic tricyclic compounds2018
Antidiabetic tricyclic compounds2018